The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Giles Colin since 2015.
The trader's CIK number is 1632546.
At the time of the last reporting, Giles Colin was the VP Clinical&Regulatory Affairs of Nexvet Biopharma Plc. (stock ticker symbol NVET).
Also see all insider trading activities at Nexvet Biopharma Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | NVET | 0 | $0 | 0 | $0 | 2,098 | $262 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-07-01 | NVET | Option Ex | 2,098 | .12 | 262 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Giles Colin (VP Clinical&Regulatory Affairs of Nexvet Biopharma Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.